Kiribati vs Sweden: Cause of death, by non-communicable diseases, ages 15-59
Kiribati
72.6%
in 2021
Sweden
71.6%
in 2021
Kiribati rank
33rd
Sweden rank
34th
Cause of death, by non-communicable diseases, ages 15-59 over time
- Kiribati
- Sweden
How they compare
Kiribati currently reports 72.6% against 71.6% in Sweden, a difference of 1.0%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Sweden ahead.
Kiribati ranks 33rd and Sweden ranks 34th of 185 countries.
Across the 3 decades both report, Kiribati averaged higher in 2 and Sweden in 1.
Head to head by decade
| Decade | Kiribati | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 71.5% | 78.5% | 6.9% | Sweden |
| 2010s | 75.6% | 75.4% | 0.1% | Kiribati |
| 2020s | 74.4% | 71.5% | 2.9% | Kiribati |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, Kiribati or Sweden?
- Kiribati, at 72.6% against 71.6% in Sweden as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59 between Kiribati and Sweden?
- 1.0%, with Kiribati ahead.
- How many years of comparable data are there for Kiribati and Sweden?
- 6 years are reported by both, from 2000 to 2021.
- How do Kiribati and Sweden rank globally for cause of death, by non-communicable diseases, ages 15-59?
- Kiribati ranks 33rd and Sweden ranks 34th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59 (% of total deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 15-59 due to non-communicable diseases divided by number of all deaths ages 15-59 expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.